Clinical Trial Update: A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the oral medicine Cenerimod for adults with systemic lupus erythematosus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Cenerimod (cenerimod)

Snippet

Sponsor: Viatris Innovation GmbH | Conditions: Lupus Erythematosus, Systemic | Phase 3 | Status: RECRUITING